In the life sciences industry, you are always seeking to improve profitability by reducing your time to market and decreasing the costs inherent in regulatory publishing. Time-consuming and error-prone PDF rendering, prevalent in medical devices and pharmaceutical organizations, is eliminated by Adlib. The resulting submission-ready PDF renditions address these challenges:
Accuracy - Guidance documents are very specific about the format of PDF files required for submissions, including details about hyperlinks, bookmarks, security settings, and more. Incorrectly formatted PDF files result in frustration and delays at the regulatory agency.
Consistency - Submissions include documents authored by many different contributors, making it difficult to achieve consistency if PDF conversion is left up to each contributor. Desktop PDF rendering represents extra work for users and introduces risk because rendering is not standardized.
Quality Control Costs - A submission document rendering process that does not produce consistent results requires more quality control and costly manual rework.
Time to Market -You can reduce submission delays and rejections by meeting compliance requirements for submission ready PDFs. Bypass the time-consuming, risky steps of manual labor by automating PDF rendering to meet the strict deadlines of the FDA and other regulatory agencies.
Internal Review Time -Your document quality assurance (QA) process may not be keeping pace with your deadlines. Adlib's solution reduces QA from hours to minutes - dramatically cutting costs, and speeding up submission preparation.
ROI on IT Investments - Your organization can leverage its existing IT investments since Adlib provides shared rendering services to the enterprise, whether you are adding SharePoint to an existing ECM platform or consolidating systems as a result of a merger or acquisition.